C O M M U N I C A T I O N S
Scheme 1. Synthesis of the Fluorescein Precursor 2
Table 1.
V
max, Km, and Fluorescence Change Associated with the
PKC-Catalyzed Phosphorylation of Peptides 14 (five different
linkers), 3, and AcSFRRRRK7
LINKER
Vmax (µmol/min‚mg)
Km (µM)
% change fluorescence
L-proline
D-proline
N-Me glycine
a
1.9
1.0
8.5
1.7
2.2
0.32
63.0
23.5
20.5
25.0
24.9
26.5
10
150%
156%
264%
164%
157%
140%
-
b
peptide 3
AcSFRRRRK
24
the magnitude and rate of fluorescence change. Several fluoro-
phore-LINKER-peptide analogues were identified that display
promising enzymological and photophysical properties (Table 1).
N-methyl glycine serves as the LINKER in the lead protein kinase
substrate. Phosphorylation of the latter generates a 264% enhance-
ment in fluorescence intensity and proceeds with a Vmax of 8.5 µmol/
min‚mg and a Km of 20.5 µM. Indeed, the Vmax is more than an or-
der of magnitude greater than that displayed by compound 3, which
lacks a LINKER residue between the fluorophore and the peptide.
Saturating [Ca2+] produces 1.2- and 2.0-fold fluorescence en-
hancements in 3 and 14 (N-Me Gly), respectively. By contrast,
enhancements of 5- and 23-fold were observed with the chemically
synthesized phosphorylated analogues of 3 and 14, respectively.
However, the large metal-induced fluorescence change in the
phosphorylated species appears to be partly offset by a reduction
in the inherent (i.e., metal-free) fluorescence of the phosphopeptides
(Supporting Information). In summary, we have prepared, via
rational design and library synthesis, a new family of protein kinase
substrates that respond to phosphoryation in a fluorescently sensitive
fashion. The ability of compounds 3 and 14 to sample PKC activity
in a variety of cell-based systems is under investigation.
Scheme 2. Synthesis of Library 14
Acknowledgment. We thank the NIH for financial support.
Supporting Information Available: Experimental details of the
synthesis, characterization, and enzymology of compound 3/library 14
(PDF). This material is available free of charge via the Internet at http://
pubs.acs.org.
We addressed the possibility of fluorophore-mediated disruption
of the kinase-catalyzed reaction by preparing a small library of 22
derivatives of 3 using the synthetic strategy outlined in Scheme 2.
A series of turn-promoting/metal chelating LINKERs was inserted
between the peptide and the fluorophore (14), which might allow
the serine moiety to be more optimally accommodated within the
active site. Following phosphorylation, the turn-inducing/chelating
ability of the LINKER should enable the iminodiacetic acid carbox-
ylates to assume a position that promotes metal coordination. The
library of 22 compounds was prepared on a cystamine-derivatized
TentaGel resin,11 which contains a disulfide bridge between the
peptide and the resin (12). The side-chain protected peptide 12 was
split into 22 portions of 10 mg each and added to a solvent-resistant
multiwell filter plate. Twenty-two Fmoc-amino acids (“LINKER”s,
see Supporting Information) were added to individual wells and
condensed with 12. The Fmoc group was removed (13) and the
product coupled to compound 2. CF3CO2H (95%) was subsequently
employed to simultaneously deprotect the phenol and carboxylic
acid moieties and transform the xanthene nucleus into the fluores-
cein derivative. Finally, all 22 compounds were cleaved from the
Tentagel resin with PKC assay buffer, which contains dithiothreitol.
The library members (14) were filtered into a receiving plate and
then assayed under standard conditions with monitoring for both
References
(1) Pines, J. Nat. Cell Biol. 1999, 1 E73-79.
(2) Blatt, N. B.; Glick, G. D. Bioorg. Med. Chem. 2001, 9, 1371-1384.
(3) Ng, T.; Squire, A.; Hansra, G.; Bornancin, F.; Prevostel, C.; Hanby, A.;
Harris, W.; Barnes, D.; Schmidt, S.; Mellor, H.; Bastiaens, P. I. H.; Parker,
P. J. Science 1999, 283, 2085-2089; Lee, C. L.; Linton, J.; Soughayer,
J. S.; Sims, C. E.; Allbritton, N. L. Nat. Biotechnol. 1999, 17, 759-762;
Nagai, Y.; Miyazaki, M.; Aoki, R.; Zama, T.; Inouye, S.; Hirose, K.; Iino,
M.; Hagiwara, M. Nat. Biotechnol. 2000, 18, 313-316.
(4) McIlroy, B. K.; Walters, J. D.; Johnson, J. D. Anal. Biochem. 1991, 195,
148-152; Bowman, B. F.; Peterson, J. A.; Stull, J. T. J. Biol. Chem. 1992,
267, 5346-5354; Post, P. L.; Trybus, K. M.; Taylor, D. L. J. Biol. Chem.
1994, 269, 12880-12887.
(5) Grynkiewicz, G.; Poenie, M.; Tsien, R. Y. J. Biol. Chem. 1985, 260, 3440-
3450; Minta, A.; Kao, J. P. Y.; Tsien, R. Y. J. Biol. Chem. 1989, 264,
8171-8178; Tsien, R. Y. Ann. ReV. Neurosci. 1989, 12, 227-253.
(6) Kwon, Y.-G.; Mendelow, M.; Lawrence, D. S. J. Biol. Chem. 1994, 269,
16725-16729.
(7) Yan, X.; Curley, K.; Lawrence, D. S. Biochem. J. 2000, 349, 709-715.
(8) Varlamova, O.; Spektor, A.; Bresnick, A. R. J. Muscle Res. Cell Motil.
2001, 22, 243-250.
(9) Sun, W.-C.; Gee, K. R.; Klaubert, D. H.; Haugland, R. P. J. Org. Chem.
1997, 62, 6469-6475.
(10) Corey, E. J.; Gras, J.-L.; Ulrich, P. Tetrahedron Lett. 1976, 809-813.
(11) Lee, T. R.; Lawrence, D. S. J. Med. Chem. 1999, 42, 784-787.
JA017530V
9
J. AM. CHEM. SOC. VOL. 124, NO. 15, 2002 3841